Updating preventive measures of children disability

Author:

Fisenko A. P.1ORCID,Zelinskaya D. I.2,Terleckaya R. N.1ORCID,Vinyarskaya I. V.1ORCID

Affiliation:

1. National Medical Research Center for Children’s Health

2. Pirogov Russian National Research Medical University

Abstract

The article provides an overview of special literature, which gives an opportunity to redefine some issues of disability prevention in children with rare (orphan) diseases, which will improve the organizational measures in this area. The prevention of children’s disability is considered as a system of measures to protect the health of the mother and child throughout childhood. The early disability prevention system in children and support for families raising children with disabilities remain among the main priorities of the State social policy of the Russian Federation. The authors describe modern technologies for reducing the genetic burden in the population from the point of view of preventing hereditary and congenital pathologies. They identify the priority areas of disability prevention in children with rare (orphan) diseases, i.e. introduction of prenatal and preimplantation diagnostics; use of the Prenatal Consultation organizational model; conducting a wider screening for congenital and hereditary metabolic diseases with the inclusion of the most common nosological forms of rare (orphan) diseases; finding pathogenetic therapy methods; increasing the knowledge of pediatricians about rare (orphan) diseases.

Publisher

The National Academy of Pediatric Science and Innovation

Subject

Pediatrics, Perinatology and Child Health

Reference43 articles.

1. Zelinskaja D.I., Terleckaja R.N. Disability of the children’s population of Russia (modern legal and medical-social processes). Monograph. M.: Jurajt; 2019: 194. (in Russ.)

2. Novikov P.V. The problem of rare (orphan) diseases in the Russian Federation: medical and normative legal aspects of its solution. Terapevticheskii arkhiv 2014; 86(12–2): 3–12. (in Russ.)

3. Berry S.A., Coughlin C.R., McCandless S., McCarter R., Seminara J., Yudkoff M., LeMons C. Developing interactions with industry in rare diseases: lessons learned and continuing challenges. Genet Med 2020; 22(1): 219–226. DOI: 10.1038/s41436-019-0616-9

4. Brenna E., Polistena B., Spandonaro F. The implementation of health technology assessment principles in public decisions concerning orphan drugs. Eur J Clin Pharmacol 2020; 22(1): 219–226. DOI: 10.1007/s00228-020-2855-7

5. Mihajlenko E.V., Kuz’min S.B. Analysis of the legal regulation of drug supply of citizens of the Russian Federation suffering from orphan diseases. Meditsinskoe pravo: teoriya i praktika 2018; 4(7): 226–230. (in Russ.)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3